151 related articles for article (PubMed ID: 25400121)
1. Interleukin-33 promotes disease progression in patients with primary biliary cirrhosis.
Sun Y; Zhang JY; Lv S; Wang H; Gong M; Du N; Liu H; Zhang N; Jing J; Zhou C; Zhang F; Wang Z
Tohoku J Exp Med; 2014 Dec; 234(4):255-61. PubMed ID: 25400121
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells: Implications for Primary Biliary Cirrhosis.
Huang Q; Chu S; Yin X; Yu X; Kang C; Li X; Qiu Y
Tohoku J Exp Med; 2016 Dec; 240(4):269-275. PubMed ID: 27916760
[TBL] [Abstract][Full Text] [Related]
3. Lower Plasma Levels of IL-35 in Patients with Primary Biliary Cirrhosis.
Li T; Huang Y; Liu P; Liu Y; Guo J; Zhang W; Gu M; Qian C; Deng A
Tohoku J Exp Med; 2018 Feb; 244(2):123-131. PubMed ID: 29445068
[TBL] [Abstract][Full Text] [Related]
4. Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis.
Qian C; Jiang T; Zhang W; Ren C; Wang Q; Qin Q; Chen J; Deng A; Zhong R
Cytokine; 2013 Oct; 64(1):172-80. PubMed ID: 23910013
[TBL] [Abstract][Full Text] [Related]
5. CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.
Chen Z; Liu S; He C; Sun J; Wang L; Chen H; Zhang F
Front Immunol; 2021; 12():578548. PubMed ID: 33815355
[No Abstract] [Full Text] [Related]
6. TNFSF9 expression in primary biliary cirrhosis and its clinical significance.
Xia R; Tang Y; Huang Y; Yao D; Zhou Y; Chen B; Chen Y; Chen S; Deng A; Zhong R
Cytokine; 2010 Jun; 50(3):311-6. PubMed ID: 20303781
[TBL] [Abstract][Full Text] [Related]
7. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
8. The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis.
Shi T; Zhang T; Zhang L; Yang Y; Zhang H; Zhang F
Medicine (Baltimore); 2015 Nov; 94(44):e1888. PubMed ID: 26554784
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis.
Reuveni D; Brezis MR; Brazowski E; Vinestock P; Leung PSC; Thakker P; Gershwin ME; Zigmond E
Front Immunol; 2021; 12():718841. PubMed ID: 34484224
[TBL] [Abstract][Full Text] [Related]
10. Implication of Increased Serum IL-31 for Primary Biliary Cholangitis.
Mu N; Lin F; Jiang Z; Liang Y; Yang Z
Immunol Invest; 2021 Aug; 50(6):662-670. PubMed ID: 32613870
[TBL] [Abstract][Full Text] [Related]
11. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J
Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
[TBL] [Abstract][Full Text] [Related]
13. [Increased expression of IL-9 in peripheral blood and liver tissues of patients with primary biliary cirrhosis].
Wang Q; Luo D; Sun X; Feng N; Li H; Hu J; Yang W; Ma X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1679-1682. PubMed ID: 27916102
[TBL] [Abstract][Full Text] [Related]
14. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.
Li Y; Wang W; Tang L; He X; Yan X; Zhang X; Zhu Y; Sun J; Shi Y; Ma X; Mackay IR; Gershwin ME; Han Y; Hou J
Hepatology; 2015 Jun; 61(6):1998-2007. PubMed ID: 25627620
[TBL] [Abstract][Full Text] [Related]
15. Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis.
Aiba Y; Harada K; Komori A; Ito M; Shimoda S; Nakamura H; Nagaoka S; Abiru S; Migita K; Ishibashi H; Nakanuma Y; Nishida N; Kawashima M; Tokunaga K; Yatsuhashi H; Nakamura M
Liver Int; 2014 May; 34(5):679-88. PubMed ID: 24016146
[TBL] [Abstract][Full Text] [Related]
16. [Correlation study of estrogen receptor with peripheral blood cytokines and serum markers in primary biliary cirrhosis patients].
Wang L; Li QM; DU HH; Wang LQ; Liu YB; Zhang W
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):336-9. PubMed ID: 22971276
[TBL] [Abstract][Full Text] [Related]
17. The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis.
Liu X; Xu H; Zhan M; Niu J
Med Sci Monit; 2019 Aug; 25():6174-6180. PubMed ID: 31420961
[TBL] [Abstract][Full Text] [Related]
18. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production.
Zachou K; Rigopoulou EI; Tsikrikoni A; Alexandrakis MG; Passam F; Kyriakou DS; Stathakis NE; Dalekos GN
J Autoimmun; 2005 Dec; 25(4):283-8. PubMed ID: 16242912
[TBL] [Abstract][Full Text] [Related]
20. Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis.
Kakuda Y; Harada K; Nakanuma Y
J Clin Pathol; 2015 Feb; 68(2):141-7. PubMed ID: 25430494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
